The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of Ph-like B-lineage acute lymphoblastic leukemia in the era of novel therapies.
 
Hamed Rahmani Youshanlouei
No Relationships to Disclose
 
Syed Abdul Mannan Shah
No Relationships to Disclose
 
Francisca Anazco
No Relationships to Disclose
 
Sinan Cetin
No Relationships to Disclose
 
Anand Patel
Consulting or Advisory Role - Abbvie; Jazz Pharmaceuticals
Research Funding - Incyte; Kronos Bio (Inst); Pfizer (Inst); SERVIER; Sumitomo Dainippon Pharma Oncology
 
Adam DuVall
No Relationships to Disclose
 
Michael Drazer
Consulting or Advisory Role - argenx; Blueprint Medicines; Cardinal Health
Travel, Accommodations, Expenses - Novartis
 
Mariam Nawas
No Relationships to Disclose
 
Angela Lager
No Relationships to Disclose
 
Carrie Fitzpatrick
No Relationships to Disclose
 
Peng Wang
No Relationships to Disclose
 
Melissa Tjota
No Relationships to Disclose
 
Sandeep Gurbuxani
No Relationships to Disclose
 
Girish Venkataraman
No Relationships to Disclose
 
Jason Cheng
No Relationships to Disclose
 
Jeremy Segal
No Relationships to Disclose
 
Olatoyosi Odenike
Consulting or Advisory Role - Abbvie; Blueprint Medicines; BMS; Bristol-Myers Squibb/Celgene (Inst); Celgene; CTI; Impact Biomedicines; Kymera; Novartis; SERVIER; Taiho Pharmaceutical; Threadwell therapeutics
Research Funding - Abbvie (Inst); Agios (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Daiichi Sankyo (Inst); Incyte (Inst); Janssen Oncology (Inst); Kartos Therapeutics (Inst); Loxo (Inst); Novartis (Inst); NS Pharma (Inst); OncoTherapy Science (Inst)
 
Wendy Stock
Honoraria - Newave Pharmaceutical; servier
Consulting or Advisory Role - AstraZeneca; Jazz Pharmaceuticals; Kura Oncology; Newave Pharmaceutical; Pfizer; SERVIER
Research Funding - Kura Oncology
Patents, Royalties, Other Intellectual Property - Royalties for a chapter in Up to Date
Travel, Accommodations, Expenses - Pfizer
 
Caner Saygin
No Relationships to Disclose